Received Dec 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | — | — |
coughing; been sick; This is a spontaneous report received from a Consumer or other non HCP. A female patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "not recovered", described as "been sick"; COUGH (non-serious), outcome "unknown", described as "coughing". Additional information: The patient reported that she had received two doses of the Pfizer COVID-19 vaccine during the period when vaccinations were widely required. Since receiving these shots, she had been experiencing ongoing illness for approximately five years, describing her condition as a roller coaster where she would feel better temporarily and then relapse. She believed the vaccines were the cause of her symptoms, although no doctor, specialist, or emergency department had been able to determine the reason for her ongoing issues. She stated that she was currently coughing and expressed that she needed medical help to get better. The healthcare provider office contacted was Med Primary Care, and no email address was available. The patient did not have her vaccine card to provide specific dates or dose details but confirmed that both doses were Pfizer COVID shots. She declined to continue with the report and preferred to stop at this point. Regulatory Authority communication included providing the Legal Department address and fax number, along with the report number. A medical information request was documented, indicating that she needed something done to help her recover. The information on the batch/lot number for BNT162b2 will be requested and submitted if and when received.